Depression and smoking: Mediating role of vagal tone and inflammation

Annals of Behavioral Medicine

Volumn 42, Issue 3, 2011, Pages 334-340

  Taylor, Laine ^a,c   Loerbroks, Adrian ^b   Herr, Raphael M ^b   Lane, Richard D ^a   Fischer, Joachim E ^b   Thayer, Julian F ^b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

Depression; Heart rate variability; Inflammation; Smoking; Vagal tone; White blood cell count

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; FIBRINOGEN;

ADULT; AGED; AIRCRAFT; ARTICLE; BLOOD; CROSS-SECTIONAL STUDY; DEPRESSION; ELECTROCARDIOGRAPHY; FEMALE; GERMANY; HEART RATE; HUMAN; IMMUNOLOGY; INDUSTRY; INFLAMMATION; LEUKOCYTE; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; QUESTIONNAIRE; SMOKING; SOCIOECONOMICS; VAGUS NERVE;

ADULT; AGED; AIRCRAFT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; DEPRESSION; ELECTROCARDIOGRAPHY; FEMALE; FIBRINOGEN; GERMANY; HEART RATE; HUMANS; INDUSTRY; INFLAMMATION; LEUKOCYTES; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; SMOKING; SOCIOECONOMIC FACTORS; VAGUS NERVE;

EID: 84857046475     PISSN: 08836612     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12160-011-9288-7     Document Type: Article

References (40)

1. Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH. Smoking and mental illness: A population-based prevalence study. JAMA. 2000;284:2606-2610.
2. Breslau N, Novak SP, Kessler RC. Psychiatric disorders and stages of smoking. Biol Psychiatry. 2004;55:69-76. (Pubitemid 38045435)
3. Tracey KJ. The inflammatory reflex. Nature. 2002;420:853-859. (Pubitemid 36019638)
4. Barutcu I, Esen AM, Kaya D, Turkmen M, Karakaya O, Melek M, et al. Cigarette smoking and heart rate variability: Dynamic influence of parasympathetic and sympathetic maneuvers. Ann Noninvasive Electrocardiol. 2005;10:324-329. (Pubitemid 41152925)
5. Thayer JF, Sternberg E. Beyond heart rate variability: Vagal regulation of allostatic systems. Ann N YAcad Sci. 2006;1088:361-372. (Pubitemid 47092035)
6. Rottenberg J. Cardiac vagal control in depression: A critical analysis. Biol Psychol. 2007;74:200-211. (Pubitemid 44969448)
7. Kemp AH, Quintana DS, Gray MA, Felmingham KL, Brown K, Gatt JM. Impact of depression and antidepressant treatment on heart rate variability: A review and meta-analysis. Biol Psychiatry. 2010;67:1067-1074.
8. Ader R, Kelley KW. A global view of twenty years of brain, behavior, and immunity. Brain Behav Immun. 2007;21:20-22. (Pubitemid 44872931)
9. Besedovsky HO, Rey AD. Physiology of psychoneuroimmunology: A personal view. Brain Behav Immun. 2007;21:34-44. (Pubitemid 44854450)
10. Irwin MR, Miller AH. Depressive disorders and immunity: 20 years of progress and discovery. Brain Behav Immun. 2007;21:374-383. (Pubitemid 46528684)
11. Pike JL, Irwin MR. Dissociation of inflammatory markers and natural killer cell activity in major depressive disorder. Brain Behav Immun. 2006;20:169-174. (Pubitemid 43202082)
12. Gorman JM, Sloan RP. Heart rate variability in depressive and anxiety disorders. Am Heart J. 2000;140:77-83.
13. Sopori ML, Kozak W. Immunomodulatory effects of cigarette smoke. J Neuroimmunol. 1998;83:148-156. (Pubitemid 28280961)
14. Bazzano LA, He J, Muntner P, Vupputuri S, Whelton PK. Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States. Ann Intern Med. 2003;138:891-897.
15. Frohlich M, Sund M, Lowel H, Imhof A, Hoffmeister A, Koenig W. Independent association of various smoking characteristics with markers of systemic inflammation in men. Results from a representative sample of the general population (MONICA Augsburg Survey 1994/95). Eur Heart J. 2003;24:1365-1372. (Pubitemid 36917708)
16. Wannamethee SG, Lowe GD, Shaper AG, Rumley A, Lennon L, Whincup PH. Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease. Eur Heart J. 2005;26:1765-1773. (Pubitemid 41219850)
17. Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EF. Systemic effects of smoking. Chest. 2007;131:1557-1566. (Pubitemid 46762366)
18. Tracey KJ. Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest. 2007;117:289-296. (Pubitemid 46203953)
19. Haensel A, Mills PJ, Nelesen RA, Ziegler MG, Dimsdale JE. The relationship between heart rate variability and inflammatory markers in cardiovascular diseases. Psychoneuroendocrinology. 2008;33:1305-1312.
20. Steptoe A, Wardle J, Marmot M. Positive affect and health-related neuroendocrine, cardiovascular, and inflammatory processes. Proc Natl Acad Sci U S A. 2005;102:6508-6512. (Pubitemid 40617473)
21. Carney RM, Freedland KE, Stein PK, Miller GE, Steinmeyer B, Rich MW, et al. Heart rate variability and markers of inflammation and coagulation in depressed patients with coronary heart disease. J Psychosom Res. 2007;62:463-467. (Pubitemid 46441261)
22. Marsland AL, Gianaros PJ, Prather AA, Jennings JR, Neumann SA, Manuck SB. Stimulated production of proinflammatory cytokines covaries inversely with heart rate variability. Psychosom Med. 2007;69:709-716. (Pubitemid 350287476)
23. von Kanel R, Thayer JF, Fischer JE. Nighttime vagal cardiac control and plasma fibrinogen levels in a population of working men and women. Ann Noninvasive Electrocardiol. 2009;14:176-184.
24. Herrmann C, Buss U, Snaith RP. HADS-D-Hospital Anxiety and Depression Scale-Deutsche Version: Ein Fragebogen zur Erfassung von Angst und Depressivität in der somatischen Medizin. Bern: Huber; 1995.
25. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J. 1996;17:354-381.
26. Penttila J, Helminen A, Jartti T, Kuusela T, Huikuri HV, Tulppo MP, et al. Time domain, geometrical and frequency domain analysis of cardiac vagal outflow: Effects of various respiratory patterns. Clin Physiol. 2001;21:365-376. (Pubitemid 32487594)
27. Clauss A. [Rapid physiological coagulation method in determination of fibrinogen.]. Acta Haematol. 1957;17:237-246.
28. Freedman LS, Schatzkin A. Sample size for studying intermediate endpoints within intervention trails or observational studies. Am J Epidemiol. 1992;136:1148-1159. (Pubitemid 23005175)
29. MacKinnon DP, Lockwood CM, Hoffman JM, West SG, Sheets V. A comparison of methods to test mediation and other intervening variable effects. Psychol Methods. 2002;7:83-104.
30. Thayer JF, Fischer JE. Heart rate variability, overnight urinary norepinephrine and C-reactive protein: Evidence for the cholinergic anti-inflammatory pathway in healthy human adults. J Intern Med. 2009;265:439-447.
31. Gilpin EA, Pierce JP. The California Tobacco Control Program and potential harm reduction through reduced cigarette consumption in continuing smokers. Nicotine Tob Res. 2002;4 Suppl 2: S157-166. (Pubitemid 36104372)
32. Olsson I, Mykletun A, Dahl AA. The Hospital Anxiety and Depression Rating Scale: A cross-sectional study of psychometrics and case finding abilities in general practice. BMC Psychiatry. 2005;5:46.
33. Cole DM, Beckmann CF, Long CJ, Matthews PM, Durcan MJ, Beaver JD. Nicotine replacement in abstinent smokers improves cognitive withdrawal symptoms with modulation of resting brain network dynamics. Neuroimage. 2010;52:590-599.
34. Dome P, Lazary J, Kalapos MP, Rihmer Z. Smoking, nicotine and neuropsychiatric disorders. Neurosci Biobehav Rev. 2010;34:295-342.
35. McCaffery JM, Papandonatos GD, Stanton C, Lloyd-Richardson EE, Niaura R. Depressive symptoms and cigarette smoking in twins from the National Longitudinal Study of Adolescent Health. Health Psychol. 2008;27:S207-215.
36. Li MD, Cheng R, Ma JZ, Swan GE. A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins. Addiction. 2003;98:23-31. (Pubitemid 36044333)
37. Jorenby DE, Leischow SJ, Nides MA, Rennard SI, Johnston JA, Hughes AR, et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med. 1999;340:685-691. (Pubitemid 29110752)
38. Evans DL, Charney DS, Lewis L, Golden RN, Gorman JM, Krishnan KR, et al. Mood disorders in the medically ill: Scientific review and recommendations. Biol Psychiatry. 2005;58:175-189. (Pubitemid 41112265)
39. Frasure-Smith N, Lesperance F, Irwin MR, Sauve C, Lesperance J, Theroux P. Depression, C-reactive protein and two-year major adverse cardiac events in men after acute coronary syndromes. Biol Psychiatry. 2007;62:302-308. (Pubitemid 47444279)
40. Lanza GA, Sgueglia GA, Cianflone D, Rebuzzi AG, Angeloni G, Sestito A, et al. Relation of heart rate variability to serum levels of C-reactive protein in patients with unstable angina pectoris. Am J Cardiol. 2006;97:1702-1706. (Pubitemid 43817853)